扶正通腑汤联合常规治疗对第三型腹膜炎的临床疗效观察

发布时间：2018-09-05 15:20

【摘要】：目的:探讨自拟扶正通腑汤联合常规西医治疗对第三型腹膜炎(TP)的临床疗效。方法:对43例TP患者做回顾性研究,其中21例西医常规治疗,采用手术引流、肠内外营养、抗生素等常规治疗。22例中西医综合治疗在西医常规治疗基础上,以自拟扶正通腑汤胃管注入、保留灌肠,配合电针、艾灸、芒硝外敷等,比较2组急性生理与慢性健康评分(APACHEII)、入住ICU天数、多脏器功能不全综合症(MODS)发生率、死亡率等差异。结果:2组入住ICU天数、MODS发生率比较差异无统计学意义,中西医综合治疗组治疗后的APACHEII评分、死亡率均低于西医治疗组,差异有统计学意义。结论:应用自拟扶正通腑汤中西医综合疗法治疗第三型腹膜炎可降低死亡率,临床推广价值较大。
[Abstract]:Objective: to investigate the clinical effect of self-made Fuzheng Tongfu decoction combined with routine western medicine on type 3 peritonitis (TP). Methods: a retrospective study was conducted in 43 patients with TP. Among them, 21 cases were treated with routine western medicine, including surgical drainage, enteral and external nutrition, antibiotics and so on. 22 cases were treated with integrated traditional Chinese and western medicine on the basis of routine western medicine treatment. With self-made Fuzheng Tongfu decoction for gastric tube injection, retention enema, electroacupuncture, moxibustion, and external application of mirabilite, the days of admission to ICU with acute physiological and chronic health score (APACHEII), the incidence of multiple organ dysfunction syndrome (MODS), mortality and so on were compared between the two groups. Results there was no significant difference in the incidence rate of mods between the two groups. The APACHEII score and mortality rate of the two groups were lower than those of the western medicine group, and the difference was statistically significant. Conclusion: the application of self-made Fuzheng Tongfu decoction in the treatment of type 3 peritonitis is of great value in clinical popularization.
【作者单位】：甘肃省华亭县人民医院;中国中医科学院中医临床基础医学研究所;
【基金】：国家自然科学基金青年基金项目(81403501)-抑郁症患者的中医人格特征及“喜”“忧”情志激活后脑电差异的研究北京市自然科学基金预探索项目(7163236)-“喜”“忧”激活“五态人”情志体验的脑电差异研究;北京市自然科学基金面上项目(7172249)-中医人格特征中“阴”“阳”属性的事件相关电位研究
【分类号】：R57

【参考文献】